Positive Carvallo sign
Specialty: Cardiovascular.
Why it occurs
- Functional tricuspid regurgitation or secondary to pulmonary hypertension
- Organic tricuspid insufficiency (rheumatic, endocarditis due to parenteral drugs, Ebstein's anomaly)
- Rheumatic tricuspid stenosis
- Myxoma of the right atrium protruding through the tricuspid valve
Initial workup
Color Doppler transthoracic echocardiogram to visualize the tricuspid valve, determine the mechanism of insufficiency (annular dilation, prolapse or leaflet restriction), measure the diameter of the inferior vena cava and its collapsibility, quantify the severity of regurgitation (EROA, regurgitant volume) and estimate the systolic pressure of the pulmonary artery; 12-lead electrocardiogram; Abdominal ultrasound to quantify liver congestion and the presence of ascites.
red flags
Significant increase in the intensity of a holosystolic or diastolic murmur in the tricuspid focus (low left sternal border) during deep inspiration (due to increased venous return and flow through the tricuspid valve), associated with extreme dyspnea, refractory central cyanosis, pain in the right upper quadrant due to acute congestive hepatomegaly, free ascites, generalized edema that compromises the abdominal wall (anasarca) or syncope. Indicates severe tricuspid valve dysfunction and critical increase in systemic venous pressures, with risk of hepatic and renal dysfunction of congestive origin.
Standard management
- Furosemide — loop diuretic indicated to aggressively reduce right ventricular preload and relieve deep systemic venous congestion; 40 to 80 mg intravenously or orally in divided doses
- Spironolactone — aldosterone antagonist, indicated for the control of water retention and ascites secondary to hepatic congestion; 50 to 100 mg daily orally, monitoring renal function and serum potassium
- Ceftriaxone — antibiotic if the new murmur is associated with fever and suspicion of tricuspid endocarditis; 2 g intravenously every 12 hours after taking blood cultures
- Sildenafil (phosphodiesterase-5 inhibitor indicated if tricuspid regurgitation is functional secondary to severe precapillary pulmonary arterial hypertension; 20 mg three times a day orally).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Cardiovascular
- Listed causes
- 4
- Treatment options
- 4